These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

552 related items for PubMed ID: 27095555

  • 1. Downregulation of CD47 and CD200 in patients with focal cortical dysplasia type IIb and tuberous sclerosis complex.
    Sun FJ, Zhang CQ, Chen X, Wei YJ, Li S, Liu SY, Zang ZL, He JJ, Guo W, Yang H.
    J Neuroinflammation; 2016 Apr 19; 13(1):85. PubMed ID: 27095555
    [Abstract] [Full Text] [Related]

  • 2. Activation of leukocyte immunoglobulin-like receptor B2 signaling pathway in cortical lesions of pediatric patients with focal cortical dysplasia type IIb and tuberous sclerosis complex.
    Yue J, Zhang C, Shi X, Wei Y, Liu L, Liu S, Yang H.
    Brain Dev; 2019 Nov 19; 41(10):829-838. PubMed ID: 31495513
    [Abstract] [Full Text] [Related]

  • 3. [Expression of autophagy-related proteins in malformations of cortical development].
    Chen S, Piao Y, Fu Y, Li Z, Liu C, Lu D.
    Zhonghua Bing Li Xue Za Zhi; 2015 May 19; 44(5):305-9. PubMed ID: 26178210
    [Abstract] [Full Text] [Related]

  • 4. Altered expression of the Plexin-B2 system in tuberous sclerosis complex and focal cortical dysplasia IIb lesions.
    Dai L, Huang J, Shen KF, Yang XL, Zhu G, Zhang L, Wang ZK, Liu SY, Liao X, Xu SL, Yang H, Li XY, Zhang CQ.
    Histol Histopathol; 2024 Sep 19; 39(9):1179-1195. PubMed ID: 38293776
    [Abstract] [Full Text] [Related]

  • 5. Altered inhibition in tuberous sclerosis and type IIb cortical dysplasia.
    Talos DM, Sun H, Kosaras B, Joseph A, Folkerth RD, Poduri A, Madsen JR, Black PM, Jensen FE.
    Ann Neurol; 2012 Apr 19; 71(4):539-51. PubMed ID: 22447678
    [Abstract] [Full Text] [Related]

  • 6. Downregulated GPR30 expression in the epileptogenic foci of female patients with focal cortical dysplasia type IIb and tuberous sclerosis complex is correlated with 18 F-FDG PET-CT values.
    Wang Z, Huang K, Yang X, Shen K, Yang L, Ruan R, Shi X, Wang M, Zhu G, Yang M, Zhang C, Lv S, Yang H, Fan X, Liu S.
    Brain Pathol; 2021 Mar 19; 31(2):346-364. PubMed ID: 33314369
    [Abstract] [Full Text] [Related]

  • 7. Oxidative stress and inflammation in a spectrum of epileptogenic cortical malformations: molecular insights into their interdependence.
    Arena A, Zimmer TS, van Scheppingen J, Korotkov A, Anink JJ, Mühlebner A, Jansen FE, van Hecke W, Spliet WG, van Rijen PC, Vezzani A, Baayen JC, Idema S, Iyer AM, Perluigi M, Mills JD, van Vliet EA, Aronica E.
    Brain Pathol; 2019 May 19; 29(3):351-365. PubMed ID: 30303592
    [Abstract] [Full Text] [Related]

  • 8. Chronic activation of anti-oxidant pathways and iron accumulation in epileptogenic malformations.
    Zimmer TS, Ciriminna G, Arena A, Anink JJ, Korotkov A, Jansen FE, van Hecke W, Spliet WG, van Rijen PC, Baayen JC, Idema S, Rensing NR, Wong M, Mills JD, van Vliet EA, Aronica E.
    Neuropathol Appl Neurobiol; 2020 Oct 19; 46(6):546-563. PubMed ID: 31869431
    [Abstract] [Full Text] [Related]

  • 9. Elevated Expression of TRPC4 in Cortical Lesions of Focal Cortical Dysplasia II and Tuberous Sclerosis Complex.
    Wang LK, Chen X, Zhang CQ, Liang C, Wei YJ, Yue J, Liu SY, Yang H.
    J Mol Neurosci; 2017 Jun 19; 62(2):222-231. PubMed ID: 28455787
    [Abstract] [Full Text] [Related]

  • 10. Expression of bone morphogenetic protein-4 in the cortical lesions of focal cortical dysplasia IIb and the tuberous sclerosis complex.
    Guo W, Zhang CQ, Shu HF, Yang MH, Yin Q, Yang H.
    J Mol Neurosci; 2013 May 19; 50(1):7-13. PubMed ID: 22752548
    [Abstract] [Full Text] [Related]

  • 11. Characteristic expression of p57/Kip2 in balloon cells in focal cortical dysplasia.
    Kimura T, Kitaura H, Masuda H, Kameyama S, Saito Y, Sugai K, Otsuki T, Nakazawa A, Morota N, Yamamoto T, Iida K, Nakagawa M, Mizuno T, Takahashi H, Kakita A.
    Neuropathology; 2015 Oct 19; 35(5):401-9. PubMed ID: 25950494
    [Abstract] [Full Text] [Related]

  • 12. Expression of tuberin and hamartin in tuberous sclerosis complex-associated and sporadic cortical dysplasia of Taylor's balloon cell type.
    Grajkowska W, Kotulska K, Matyja E, Larysz-Brysz M, Mandera M, Roszkowski M, Domańska-Pakieła D, Lewik-Kowalik J, Jóźwiak S.
    Folia Neuropathol; 2008 Oct 19; 46(1):43-8. PubMed ID: 18368626
    [Abstract] [Full Text] [Related]

  • 13. Doublecortin-like (DCL) expression in focal cortical dysplasia and cortical tubers.
    Boer K, Lucassen PJ, Spliet WG, Vreugdenhil E, van Rijen PC, Troost D, Jansen FE, Aronica E.
    Epilepsia; 2009 Dec 19; 50(12):2629-37. PubMed ID: 19583781
    [Abstract] [Full Text] [Related]

  • 14. mTOR Hyperactivity Levels Influence the Severity of Epilepsy and Associated Neuropathology in an Experimental Model of Tuberous Sclerosis Complex and Focal Cortical Dysplasia.
    Nguyen LH, Mahadeo T, Bordey A.
    J Neurosci; 2019 Apr 03; 39(14):2762-2773. PubMed ID: 30700531
    [Abstract] [Full Text] [Related]

  • 15. Expression of the interleukin 6 system in cortical lesions from patients with tuberous sclerosis complex and focal cortical dysplasia type IIb.
    Shu HF, Zhang CQ, Yin Q, An N, Liu SY, Yang H.
    J Neuropathol Exp Neurol; 2010 Aug 03; 69(8):838-49. PubMed ID: 20613633
    [Abstract] [Full Text] [Related]

  • 16. Impaired oligodendroglial turnover is associated with myelin pathology in focal cortical dysplasia and tuberous sclerosis complex.
    Scholl T, Mühlebner A, Ricken G, Gruber V, Fabing A, Samueli S, Gröppel G, Dorfer C, Czech T, Hainfellner JA, Prabowo AS, Reinten RJ, Hoogendijk L, Anink JJ, Aronica E, Feucht M.
    Brain Pathol; 2017 Nov 03; 27(6):770-780. PubMed ID: 27750396
    [Abstract] [Full Text] [Related]

  • 17. Upregulation of HMGB1-TLR4 inflammatory pathway in focal cortical dysplasia type II.
    Zhang Z, Liu Q, Liu M, Wang H, Dong Y, Ji T, Liu X, Jiang Y, Cai L, Wu Y.
    J Neuroinflammation; 2018 Jan 30; 15(1):27. PubMed ID: 29382328
    [Abstract] [Full Text] [Related]

  • 18. mTOR pathway activation in focal cortical dysplasia.
    Kumari K, Sharma MC, Kakkar A, Malgulwar PB, Pathak P, Suri V, Sarkar C, Chandra SP, Faruq M.
    Ann Diagn Pathol; 2020 Jun 30; 46():151523. PubMed ID: 32325422
    [Abstract] [Full Text] [Related]

  • 19. mTOR-dependent abnormalities in autophagy characterize human malformations of cortical development: evidence from focal cortical dysplasia and tuberous sclerosis.
    Yasin SA, Ali AM, Tata M, Picker SR, Anderson GW, Latimer-Bowman E, Nicholson SL, Harkness W, Cross JH, Paine SM, Jacques TS.
    Acta Neuropathol; 2013 Aug 30; 126(2):207-18. PubMed ID: 23728790
    [Abstract] [Full Text] [Related]

  • 20. Tissue plasminogen activator and urokinase plasminogen activator in human epileptogenic pathologies.
    Iyer AM, Zurolo E, Boer K, Baayen JC, Giangaspero F, Arcella A, Di Gennaro GC, Esposito V, Spliet WG, van Rijen PC, Troost D, Gorter JA, Aronica E.
    Neuroscience; 2010 May 19; 167(3):929-45. PubMed ID: 20219643
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.